<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-04-12" modified="2020-10-07" version="205">
<accession>Q07666</accession>
<accession>D3DPP3</accession>
<accession>Q6PJX7</accession>
<accession>Q8NB97</accession>
<accession>Q99760</accession>
<name>KHDR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>KH domain-containing, RNA-binding, signal transduction-associated protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>GAP-associated tyrosine phosphoprotein p62</fullName>
</alternativeName>
<alternativeName>
<fullName>Src-associated in mitosis 68 kDa protein</fullName>
<shortName>Sam68</shortName>
</alternativeName>
<alternativeName>
<fullName>p21 Ras GTPase-activating protein-associated p62</fullName>
</alternativeName>
<alternativeName>
<fullName>p68</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="50">KHDRBS1</name>
<name type="synonym" evidence="38">SAM68</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="41 44">
<citation type="journal article" date="1992" name="Cell" volume="69" first="551" last="558">
<title>Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62.</title>
<authorList>
<person name="Wong G."/>
<person name="Muller O."/>
<person name="Clark R."/>
<person name="Conroy L."/>
<person name="Moran M.F."/>
<person name="Polakis P."/>
<person name="McCormick F."/>
</authorList>
<dbReference type="PubMed" id="1374686"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90455-l"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>RNA-BINDING</scope>
<scope>METHYLATION</scope>
<scope>INTERACTION WITH RASA1</scope>
<source>
<tissue evidence="44">Fetal brain</tissue>
</source>
</reference>
<reference key="2" evidence="41 45">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="3129" last="3132">
<title>A role for Sam68 in cell cycle progression antagonized by a spliced variant within the KH domain.</title>
<authorList>
<person name="Barlat I."/>
<person name="Maurier F."/>
<person name="Duchesne M."/>
<person name="Guitard E."/>
<person name="Tocque B."/>
<person name="Schweighoffer F."/>
</authorList>
<dbReference type="PubMed" id="9013542"/>
<dbReference type="DOI" id="10.1074/jbc.272.6.3129"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<source>
<tissue evidence="35">Placenta</tissue>
</source>
</reference>
<reference key="3" evidence="41 49">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue evidence="49">Brain</tissue>
</source>
</reference>
<reference key="4" evidence="41 48">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6" evidence="41 46">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue evidence="47">Lymph</tissue>
<tissue evidence="46">Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 18-31; 57-96; 103-131; 139-152; 176-185; 292-302 AND 316-340</scope>
<scope>METHYLATION AT ARG-320; ARG-331 AND ARG-340</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="8" evidence="41">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="6214" last="6219">
<title>Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling.</title>
<authorList>
<person name="Fusaki N."/>
<person name="Iwamatsu A."/>
<person name="Iwashima M."/>
<person name="Fujisawa J."/>
</authorList>
<dbReference type="PubMed" id="9045636"/>
<dbReference type="DOI" id="10.1074/jbc.272.10.6214"/>
</citation>
<scope>PROTEIN SEQUENCE OF 102-110 AND 169-175 (ISOFORMS 1/2)</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH LCK; FYN; PTPN6; PLCG1; GRB2; CBL; JAK3 AND PIK3R1</scope>
</reference>
<reference key="9" evidence="41">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="959" last="969">
<title>T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis.</title>
<authorList>
<person name="Venables J.P."/>
<person name="Vernet C."/>
<person name="Chew S.L."/>
<person name="Elliott D.J."/>
<person name="Cowmeadow R.B."/>
<person name="Wu J."/>
<person name="Cooke H.J."/>
<person name="Artzt K."/>
<person name="Eperon I.C."/>
</authorList>
<dbReference type="PubMed" id="10332027"/>
<dbReference type="DOI" id="10.1093/hmg/8.6.959"/>
</citation>
<scope>INTERACTION WITH KHDRBS3</scope>
<source>
<tissue evidence="19">Testis</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="6114" last="6126">
<title>Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.</title>
<authorList>
<person name="Derry J.J."/>
<person name="Richard S."/>
<person name="Valderrama Carvajal H."/>
<person name="Ye X."/>
<person name="Vasioukhin V."/>
<person name="Cochrane A.W."/>
<person name="Chen T."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="10913193"/>
<dbReference type="DOI" id="10.1128/mcb.20.16.6114-6126.2000"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PTK6</scope>
</reference>
<reference key="11" evidence="41">
<citation type="journal article" date="2001" name="Cell. Immunol." volume="211" first="30" last="36">
<title>Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway.</title>
<authorList>
<person name="Sanchez-Margalet V."/>
<person name="Martin-Romero C."/>
</authorList>
<dbReference type="PubMed" id="11585385"/>
<dbReference type="DOI" id="10.1006/cimm.2001.1815"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="12" evidence="41">
<citation type="journal article" date="2003" name="Mol. Biol. Cell" volume="14" first="274" last="287">
<title>Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1.</title>
<authorList>
<person name="Cote J."/>
<person name="Boisvert F.-M."/>
<person name="Boulanger M.-C."/>
<person name="Bedford M.T."/>
<person name="Richard S."/>
</authorList>
<dbReference type="PubMed" id="12529443"/>
<dbReference type="DOI" id="10.1091/mbc.e02-08-0484"/>
</citation>
<scope>METHYLATION AT ARG-45; ARG-52; ARG-304; ARG-310; ARG-315; ARG-320 AND ARG-325</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Nat. Methods" volume="1" first="119" last="126">
<title>Identifying and quantifying in vivo methylation sites by heavy methyl SILAC.</title>
<authorList>
<person name="Ong S.E."/>
<person name="Mittler G."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="15782174"/>
<dbReference type="DOI" id="10.1038/nmeth715"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-340</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14" evidence="41">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="3781" last="3789">
<title>The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity.</title>
<authorList>
<person name="Babic I."/>
<person name="Jakymiw A."/>
<person name="Fujita D.J."/>
</authorList>
<dbReference type="PubMed" id="15021911"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207484"/>
</citation>
<scope>ACETYLATION</scope>
<scope>INTERACTION WITH RNA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="38639" last="38647">
<title>Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.</title>
<authorList>
<person name="Lukong K.E."/>
<person name="Larocque D."/>
<person name="Tyner A.L."/>
<person name="Richard S."/>
</authorList>
<dbReference type="PubMed" id="16179349"/>
<dbReference type="DOI" id="10.1074/jbc.m505802200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-435; TYR-440 AND TYR-443</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-435; TYR-440 AND TYR-443</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1774" first="1339" last="1350">
<title>The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G.</title>
<authorList>
<person name="Ulke-Lemee A."/>
<person name="Trinkle-Mulcahy L."/>
<person name="Chaulk S."/>
<person name="Bernstein N.K."/>
<person name="Morrice N."/>
<person name="Glover M."/>
<person name="Lamond A.I."/>
<person name="Moorhead G.B.G."/>
</authorList>
<dbReference type="PubMed" id="17890166"/>
<dbReference type="DOI" id="10.1016/j.bbapap.2007.07.015"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH ILF2; ILF3; YLPM1; RBMX; NCOA5 AND PPP1CA</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="176" first="929" last="939">
<title>The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.</title>
<authorList>
<person name="Paronetto M.P."/>
<person name="Achsel T."/>
<person name="Massiello A."/>
<person name="Chalfant C.E."/>
<person name="Sette C."/>
</authorList>
<dbReference type="PubMed" id="17371836"/>
<dbReference type="DOI" id="10.1083/jcb.200701005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HNRNPA1</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF VAL-229</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-29</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-175</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="1235" last="1247">
<title>The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.</title>
<authorList>
<person name="Pedrotti S."/>
<person name="Bielli P."/>
<person name="Paronetto M.P."/>
<person name="Ciccosanti F."/>
<person name="Fimia G.M."/>
<person name="Stamm S."/>
<person name="Manley J.L."/>
<person name="Sette C."/>
</authorList>
<dbReference type="PubMed" id="20186123"/>
<dbReference type="DOI" id="10.1038/emboj.2010.19"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="RNA" volume="17" first="1344" last="1356">
<title>The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway.</title>
<authorList>
<person name="Coyle J.H."/>
<person name="Bor Y.C."/>
<person name="Rekosh D."/>
<person name="Hammarskjold M.L."/>
</authorList>
<dbReference type="PubMed" id="21613532"/>
<dbReference type="DOI" id="10.1261/rna.2616111"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E29921" last="E29921">
<title>Localization of nucleoporin Tpr to the nuclear pore complex is essential for Tpr mediated regulation of the export of unspliced RNA.</title>
<authorList>
<person name="Rajanala K."/>
<person name="Nandicoori V.K."/>
</authorList>
<dbReference type="PubMed" id="22253824"/>
<dbReference type="DOI" id="10.1371/journal.pone.0029921"/>
</citation>
<scope>LACK OF FUNCTION IN UNSPLICED RNA EXPORT</scope>
<scope>LACK OF INTERACTION WITH TPR</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-20; SER-29; THR-33; SER-150 AND THR-183</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="EMBO Rep." volume="15" first="419" last="427">
<title>The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.</title>
<authorList>
<person name="Bielli P."/>
<person name="Busa R."/>
<person name="Di Stasi S.M."/>
<person name="Munoz M.J."/>
<person name="Botti F."/>
<person name="Kornblihtt A.R."/>
<person name="Sette C."/>
</authorList>
<dbReference type="PubMed" id="24514149"/>
<dbReference type="DOI" id="10.1002/embr.201338241"/>
</citation>
<scope>INTERACTION WITH ZBTB7A</scope>
<scope>REGION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-58 AND SER-390</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-282; ARG-284; ARG-331 AND ARG-340</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-102</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-102</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-102</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-102</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="10355" last="10355">
<title>Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68.</title>
<authorList>
<person name="Feracci M."/>
<person name="Foot J.N."/>
<person name="Grellscheid S.N."/>
<person name="Danilenko M."/>
<person name="Stehle R."/>
<person name="Gonchar O."/>
<person name="Kang H.S."/>
<person name="Dalgliesh C."/>
<person name="Meyer N.H."/>
<person name="Liu Y."/>
<person name="Lahat A."/>
<person name="Sattler M."/>
<person name="Eperon I.C."/>
<person name="Elliott D.J."/>
<person name="Dominguez C."/>
</authorList>
<dbReference type="PubMed" id="26758068"/>
<dbReference type="DOI" id="10.1038/ncomms10355"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>FUNCTION</scope>
<scope>SELF-ASSOCIATION</scope>
<scope>MUTAGENESIS OF TYR-241</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-96; LYS-102; LYS-139; LYS-175 AND LYS-432</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2018" name="Mol. Cell. Proteomics" volume="17" first="925" last="947">
<title>Phosphoproteomics analysis identifies novel candidate substrates of the non-receptor tyrosine kinase, SRMS.</title>
<authorList>
<person name="Goel R.K."/>
<person name="Paczkowska M."/>
<person name="Reimand J."/>
<person name="Napper S."/>
<person name="Lukong K.E."/>
</authorList>
<dbReference type="PubMed" id="29496907"/>
<dbReference type="DOI" id="10.1074/mcp.ra118.000643"/>
</citation>
<scope>INTERACTION WITH SRMS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="28893" last="28901">
<title>Structural basis for homodimerization of the Src-associated during mitosis, 68-kDa protein (Sam68) Qua1 domain.</title>
<authorList>
<person name="Meyer N.H."/>
<person name="Tripsianes K."/>
<person name="Vincendeau M."/>
<person name="Madl T."/>
<person name="Kateb F."/>
<person name="Brack-Werner R."/>
<person name="Sattler M."/>
</authorList>
<dbReference type="PubMed" id="20610388"/>
<dbReference type="DOI" id="10.1074/jbc.m110.126185"/>
</citation>
<scope>STRUCTURE BY NMR OF 97-135</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF TYR-103; GLU-110 AND PHE-118</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Structure" volume="19" first="1496" last="1508">
<title>Crystal structures of the armadillo repeat domain of adenomatous polyposis coli and its complex with the tyrosine-rich domain of Sam68.</title>
<authorList>
<person name="Morishita E.C."/>
<person name="Murayama K."/>
<person name="Kato-Murayama M."/>
<person name="Ishizuka-Katsura Y."/>
<person name="Tomabechi Y."/>
<person name="Hayashi T."/>
<person name="Terada T."/>
<person name="Handa N."/>
<person name="Shirouzu M."/>
<person name="Akiyama T."/>
<person name="Yokoyama S."/>
</authorList>
<dbReference type="PubMed" id="22000517"/>
<dbReference type="DOI" id="10.1016/j.str.2011.07.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 365-419 IN COMPLEX WITH APC</scope>
<scope>PHOSPHORYLATION AT TYR-387</scope>
<scope>MUTAGENESIS OF GLU-381; TYR-383 AND GLU-384</scope>
</reference>
<comment type="function">
<text evidence="15 24 26 28 29 31 33">Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. According to some authors, is not involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species according to (PubMed:22253824). RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). Can regulate CD44 alternative splicing in a Ras pathway-dependent manner (By similarity). In cooperation with HNRNPA1 modulates alternative splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and of SMN1 (PubMed:17371836, PubMed:20186123). Can regulate alternative splicing of NRXN1 and NRXN3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. In a neuronal activity-dependent manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is antagonistic for regulation of NXRN3 alternative splicing at AS4 (By similarity).</text>
</comment>
<comment type="function">
<text evidence="35">Isoform 3, which is expressed in growth-arrested cells only, inhibits S phase.</text>
</comment>
<comment type="subunit">
<text evidence="15 16 19 20 21 23 26 27 30 32 34 36">Self-associates to form homooligomers when bound to RNA, oligomerization appears to be limited when binding to proteins; dimerization increases RNA affinity (PubMed:26758068, PubMed:20610388). Interacts with KHDRBS3/SLIM-2 (PubMed:10332027). Interacts with KHDRBS2/SLIM-1; heterooligomer formation of KHDRBS family proteins may modulate RNA substrate specificity (By similarity). Interacts with RASA1, LCK, FYN, PTPN6, PLCG1, GRB2, CBL, JAK3, PIK3R, STAT3, APC, HNRNPA1 (PubMed:1374686, PubMed:9045636, PubMed:10332027, PubMed:11585385, PubMed:17371836, PubMed:22000517). Interacts with PTK6 (via SH3 and SH2 domains) (PubMed:10913193). Forms a complex with ILF2, ILF3, YLPM1, RBMX, NCOA5 and PPP1CA (PubMed:17890166). Does not interact with TPR (PubMed:22253824). Interacts with RBMY1A1, PRMT1 (By similarity). Binds WBP4/FBP21 (via WW domains), FNBP4/FBP30 (via WW domains). Interacts (via Arg/Gly-rich-flanked Pro-rich regions) with FYN (via the SH3 domain) (By similarity). Interacts with the non-receptor tyrosine kinase SRMS; the interaction leads to phosphorylation of KHDRBS1 (PubMed:29496907). Interacts with ZBTB7A; negatively regulates KHDRBS1 splicing activity toward BCL2L1 (PubMed:24514149).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-727707">
<id>P25054</id>
<label>APC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-352662">
<id>P09651</id>
<label>HNRNPA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-304185">
<id>P61978</id>
<label>HNRNPK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-518246">
<id>P52333</id>
<label>JAK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-1364">
<id>Q07666</id>
<label>KHDRBS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-679562">
<id>P51531</id>
<label>SMARCA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-625518">
<id>P15498</id>
<label>VAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-2795384">
<id>O95365</id>
<label>ZBTB7A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-1401">
<id>P06240</id>
<label>Lck</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1364">
<id>Q07666</id>
</interactant>
<interactant intactId="EBI-520244">
<id>P23727</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="23 34">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="34">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Membrane</location>
</subcellularLocation>
<text evidence="34">Predominantly located in the nucleus but also located partially in the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q07666-1</id>
<name evidence="23">1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q07666-2</id>
<name evidence="41">2</name>
<sequence type="described" ref="VSP_051719"/>
</isoform>
<isoform>
<id>Q07666-3</id>
<name evidence="35">3</name>
<name evidence="35">DeltaKH</name>
<sequence type="described" ref="VSP_051720"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="35">Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver.</text>
</comment>
<comment type="developmental stage">
<text evidence="35">Isoform 3 is only expressed in growth-arrested cells.</text>
</comment>
<comment type="domain">
<text evidence="15">The KH domain is required for binding to RNA.</text>
</comment>
<comment type="domain">
<text evidence="14">The Pro-rich domains are flanked by Arg/Gly-rich motifs which can be asymmetric dimethylated on arginine residues to give the DMA/Gly-rich regions. Selective methylation on these motifs can modulate protein-protein interactions (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="21 25 26 30 34 36">Tyrosine phosphorylated by several non-receptor tyrosine kinases including LCK, FYN and JAK3. Also tyrosine phosphorylated by the non-receptor tyrosine kinase SRMS in an EGF-dependent manner (PubMed:29496907). Negatively correlates with ability to bind RNA but required for many interactions with proteins. Phosphorylation by PTK6 negatively regulates its RNA binding ability. Phosphorylation by PTK6 at Tyr-440 dictates the nuclear localization of KHDRBS1. Phosphorylation at Tyr-387 disrupts interaction with APC. Phosphorylation at tyrosine residues by FYN inverts activity on modulation of BCL2L1 alternative splicing.</text>
</comment>
<comment type="PTM">
<text evidence="24">Acetylated. Positively correlates with ability to bind RNA.</text>
</comment>
<comment type="PTM">
<text evidence="22 23 37">Arginine methylation is required for nuclear localization. Also can affect interaction with other proteins. Inhibits interaction with Src-like SH3 domains, but not interaction with WW domains of WBP4/FBP21 AND FNBP4/FBP30.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the KHDRBS family.</text>
</comment>
<comment type="sequence caution" evidence="41">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH10132" version="1"/>
</conflict>
<text>Intron retention.</text>
</comment>
<dbReference type="EMBL" id="M88108">
<property type="protein sequence ID" value="AAA59990.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U78971">
<property type="protein sequence ID" value="AAB47504.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK091346">
<property type="protein sequence ID" value="BAC03643.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139249">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445248">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX07576.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX07577.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000717">
<property type="protein sequence ID" value="AAH00717.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010132">
<property type="protein sequence ID" value="AAH10132.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC019109">
<property type="protein sequence ID" value="AAH19109.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS350.1">
<molecule id="Q07666-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS60067.1">
<molecule id="Q07666-3"/>
</dbReference>
<dbReference type="PIR" id="A38219">
<property type="entry name" value="A38219"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001258807.1">
<molecule id="Q07666-3"/>
<property type="nucleotide sequence ID" value="NM_001271878.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006550.1">
<molecule id="Q07666-1"/>
<property type="nucleotide sequence ID" value="NM_006559.2"/>
</dbReference>
<dbReference type="PDB" id="2XA6">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=97-135"/>
</dbReference>
<dbReference type="PDB" id="3QHE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="B/D=365-419"/>
</dbReference>
<dbReference type="PDBsum" id="2XA6"/>
<dbReference type="PDBsum" id="3QHE"/>
<dbReference type="BMRB" id="Q07666"/>
<dbReference type="SMR" id="Q07666"/>
<dbReference type="BioGRID" id="115900">
<property type="interactions" value="224"/>
</dbReference>
<dbReference type="CORUM" id="Q07666"/>
<dbReference type="DIP" id="DIP-29007N"/>
<dbReference type="IntAct" id="Q07666">
<property type="interactions" value="129"/>
</dbReference>
<dbReference type="MINT" id="Q07666"/>
<dbReference type="STRING" id="9606.ENSP00000313829"/>
<dbReference type="iPTMnet" id="Q07666"/>
<dbReference type="MetOSite" id="Q07666"/>
<dbReference type="PhosphoSitePlus" id="Q07666"/>
<dbReference type="SwissPalm" id="Q07666"/>
<dbReference type="BioMuta" id="KHDRBS1"/>
<dbReference type="DMDM" id="62511098"/>
<dbReference type="EPD" id="Q07666"/>
<dbReference type="jPOST" id="Q07666"/>
<dbReference type="MassIVE" id="Q07666"/>
<dbReference type="MaxQB" id="Q07666"/>
<dbReference type="PaxDb" id="Q07666"/>
<dbReference type="PeptideAtlas" id="Q07666"/>
<dbReference type="PRIDE" id="Q07666"/>
<dbReference type="ProteomicsDB" id="58523">
<molecule id="Q07666-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58524">
<molecule id="Q07666-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58525">
<molecule id="Q07666-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q07666-1">
<molecule id="Q07666-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q07666-3">
<molecule id="Q07666-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3944">
<property type="antibodies" value="312 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10657"/>
<dbReference type="Ensembl" id="ENST00000327300">
<molecule id="Q07666-1"/>
<property type="protein sequence ID" value="ENSP00000313829"/>
<property type="gene ID" value="ENSG00000121774"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000492989">
<molecule id="Q07666-3"/>
<property type="protein sequence ID" value="ENSP00000417731"/>
<property type="gene ID" value="ENSG00000121774"/>
</dbReference>
<dbReference type="GeneID" id="10657"/>
<dbReference type="KEGG" id="hsa:10657"/>
<dbReference type="UCSC" id="uc001bua.3">
<molecule id="Q07666-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10657"/>
<dbReference type="DisGeNET" id="10657"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000121774.17"/>
<dbReference type="GeneCards" id="KHDRBS1"/>
<dbReference type="HGNC" id="HGNC:18116">
<property type="gene designation" value="KHDRBS1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000121774">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602489">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q07666"/>
<dbReference type="OpenTargets" id="ENSG00000121774"/>
<dbReference type="PharmGKB" id="PA30092"/>
<dbReference type="eggNOG" id="KOG1588">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155718"/>
<dbReference type="HOGENOM" id="CLU_034976_0_0_1"/>
<dbReference type="InParanoid" id="Q07666"/>
<dbReference type="KO" id="K13198"/>
<dbReference type="OMA" id="GQDHGAR"/>
<dbReference type="OrthoDB" id="1012406at2759"/>
<dbReference type="PhylomeDB" id="Q07666"/>
<dbReference type="TreeFam" id="TF314878"/>
<dbReference type="PathwayCommons" id="Q07666"/>
<dbReference type="Reactome" id="R-HSA-8849468">
<property type="pathway name" value="PTK6 Regulates Proteins Involved in RNA Processing"/>
</dbReference>
<dbReference type="SignaLink" id="Q07666"/>
<dbReference type="SIGNOR" id="Q07666"/>
<dbReference type="BioGRID-ORCS" id="10657">
<property type="hits" value="37 hits in 879 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KHDRBS1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q07666"/>
<dbReference type="GeneWiki" id="KHDRBS1"/>
<dbReference type="GenomeRNAi" id="10657"/>
<dbReference type="Pharos" id="Q07666">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q07666"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q07666">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000121774">
<property type="expression patterns" value="Expressed in forebrain and 250 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q07666">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070618">
<property type="term" value="C:Grb2-Sos complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008143">
<property type="term" value="F:poly(A) binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008266">
<property type="term" value="F:poly(U) RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035591">
<property type="term" value="F:signaling adaptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046833">
<property type="term" value="P:positive regulation of RNA export from nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045948">
<property type="term" value="P:positive regulation of translational initiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046831">
<property type="term" value="P:regulation of RNA export from nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="DisProt" id="DP01705"/>
<dbReference type="Gene3D" id="3.30.1370.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00619"/>
<dbReference type="InterPro" id="IPR004087">
<property type="entry name" value="KH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004088">
<property type="entry name" value="KH_dom_type_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036612">
<property type="entry name" value="KH_dom_type_1_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR032571">
<property type="entry name" value="Qua1_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032335">
<property type="entry name" value="Sam68-YY"/>
</dbReference>
<dbReference type="Pfam" id="PF00013">
<property type="entry name" value="KH_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16274">
<property type="entry name" value="Qua1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16568">
<property type="entry name" value="Sam68-YY"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00322">
<property type="entry name" value="KH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54791">
<property type="entry name" value="SSF54791"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50084">
<property type="entry name" value="KH_TYPE_1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0729">SH3-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="KH domain-containing, RNA-binding, signal transduction-associated protein 1" id="PRO_0000050124">
<location>
<begin position="1"/>
<end position="443"/>
</location>
</feature>
<feature type="domain" description="KH" evidence="18">
<location>
<begin position="171"/>
<end position="197"/>
</location>
</feature>
<feature type="region of interest" description="Involved in homodimerization" evidence="43">
<location>
<begin position="100"/>
<end position="260"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HNRNPA1" evidence="26">
<location>
<begin position="351"/>
<end position="443"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ZBTB7A" evidence="32">
<location>
<begin position="400"/>
<end position="420"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich" evidence="17">
<location>
<begin position="34"/>
<end position="41"/>
</location>
</feature>
<feature type="compositionally biased region" description="DMA/Gly-rich" evidence="17">
<location>
<begin position="44"/>
<end position="55"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich" evidence="17">
<location>
<begin position="59"/>
<end position="89"/>
</location>
</feature>
<feature type="compositionally biased region" description="DMA/Gly-rich" evidence="17">
<location>
<begin position="282"/>
<end position="292"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich" evidence="17">
<location>
<begin position="295"/>
<end position="301"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Gly-rich" evidence="17">
<location>
<begin position="302"/>
<end position="332"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich" evidence="17">
<location>
<begin position="334"/>
<end position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT1" evidence="22">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; partial; by PRMT1" evidence="22">
<location>
<position position="52"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="58"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK1" evidence="15">
<location>
<position position="84"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="113"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="150"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="175"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="183"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="7">
<location>
<position position="282"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="7">
<location>
<position position="284"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="15">
<location>
<position position="291"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT1" evidence="22">
<location>
<position position="304"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="22">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="22">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; in A2780 ovarian carcinoma cell line" evidence="37">
<location>
<position position="320"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="22">
<location>
<position position="320"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="22">
<location>
<position position="325"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="15">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; in A2780 ovarian carcinoma cell line" evidence="37">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1; alternate" evidence="7 37">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; in A2780 ovarian carcinoma cell line" evidence="37">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="2 7">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="42">
<location>
<position position="387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="390"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="25">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="25">
<location>
<position position="440"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="25">
<location>
<position position="443"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="96"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 10 11 12 13">
<location>
<position position="102"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="139"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="175"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="432"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_051719" evidence="39">
<location>
<begin position="37"/>
<end position="61"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_051720" evidence="40">
<location>
<begin position="169"/>
<end position="207"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs homodimerization." evidence="29">
<original>Y</original>
<variation>S</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs homodimerization." evidence="29">
<original>E</original>
<variation>A</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts homodimerization, impairs influence on alternative splicing." evidence="29">
<original>F</original>
<variation>S</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts binding to poly(A). Decreased binding to the BCL2L1 mRNA. Loss of function in BCL2L1 splicing. Changed nuclear localization." evidence="26">
<original>V</original>
<variation>F</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="mutagenesis site" description="Fails to influence alternative splicing of CD44, NRXN2 and NRXN3." evidence="33">
<original>Y</original>
<variation>E</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with APC." evidence="30">
<original>E</original>
<variation>K</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with APC." evidence="30">
<original>Y</original>
<variation>K</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with APC." evidence="30">
<original>E</original>
<variation>K</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the nuclear localization." evidence="25">
<original>Y</original>
<variation>F</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely blocks nuclear localization." evidence="25">
<original>Y</original>
<variation>F</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the nuclear localization." evidence="25">
<original>Y</original>
<variation>F</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="100"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="119"/>
<end position="134"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XA6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15782174"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q60749"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q91V33"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255"/>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00117"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10332027"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10913193"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11585385"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529443"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1374686"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15021911"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16179349"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17371836"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17890166"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20186123"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20610388"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22000517"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22253824"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24514149"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26758068"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29496907"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9013542"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9045636"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1374686"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9013542"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<evidence key="42" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22000517"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26758068"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAA59990.1"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAB47504.1"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAH00717.1"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAH19109.1"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AL139249"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="BAC03643.1"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:18116"/>
</source>
</evidence>
<sequence length="443" mass="48227" checksum="59FB4DB6FB4DBE98" modified="1996-11-01" version="1">MQRRDDPAARMSRSSGRSGSMDPSGAHPSVRQTPSRQPPLPHRSRGGGGGSRGGARASPATQPPPLLPPSATGPDATVGGPAPTPLLPPSATASVKMEPENKYLPELMAEKDSLDPSFTHAMQLLTAEIEKIQKGDSKKDDEENYLDLFSHKNMKLKERVLIPVKQYPKFNFVGKILGPQGNTIKRLQEETGAKISVLGKGSMRDKAKEEELRKGGDPKYAHLNMDLHVFIEVFGPPCEAYALMAHAMEEVKKFLVPDMMDDICQEQFLELSYLNGVPEPSRGRGVPVRGRGAAPPPPPVPRGRGVGPPRGALVRGTPVRGAITRGATVTRGVPPPPTVRGAPAPRARTAGIQRIPLPPPPAPETYEEYGYDDTYAEQSYEGYEGYYSQSQGDSEYYDYGHGEVQDSYEAYGQDDWNGTRPSLKAPPARPVKGAYREHPYGRY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

